Related Experiment Video
Updated: Aug 8, 2026

Generation and Genetic Manipulation of Human Cervical Organoids
Published on: March 10, 2026
Selective inhibition of cell growth by activin in SNU-16 cells
Young-Il Kim1, Hee-Joo Lee, Inkoo Khang
1East-West Medical Research Institute, Kyung Hee University, Seoul, South Korea.
Aim:
To investigate whether activin regulates the cell proliferation of human gastric cancer cell line SNU-16 through the mRNA changes in activin receptors, Smads and p21(CIP1/WAF1).
Methods:
The human gastric cancer cell lines were cultured, RNAs were purified, and RT-PCRs were carried out with specifically designed primer for each gene. Among them, the two cell lines SNU-5 and SNU-16 were cultured with activin A for 24, 48 and 72 h. The cell proliferation was measured by MTT assay. For SNU-16, changes in ActRIA, ActRIB, ActRIIA, ActRIIB, Smad2, Smad4, Smad7, and p21(CIP1/WAF1) mRNAs were detected with RT-PCR after the cells were cultured with activin A for 24, 48 and 72 h.
Results:
The proliferation of SNU-16 cells was down regulated by activin A whereas other cells showed no change. Basal level of inhibin/activin subunits, activin receptors, Smads, and p21(CIP1/WAF1) except for activin betaB mRNAs was observed to have differential expression patterns in the human gastric cancer cell lines, AGS, KATO III, SNU-1, SNU-5, SNU-16, SNU-484, SNU-601, SNU-638, SNU-668, and SNU-719. Interestingly, significantly higher expressions of ActR IIA and IIB mRNAs were observed in SNU-16 cells when compared to other cells. After activin treatment, ActR IA, IB, and IIA mRNA levels were decreased whereas ActR IIB mRNA level increased in SNU-16 cells. Smad4 mRNA increased for up to 48 h whereas Smad7 mRNA increased sharply at 24 h and returned to the initial level at 48 h in SNU-16 cells. In addition, expression of the p21(CIP1/WAF1), the mitotic inhibitor, peaked at 72 h after activin treatment in SNU-16 cells.
Conclusion:
Our results suggest that inhibition of cell growth by activin is regulated by the negative feedback effect of Smad7 on the activin signaling pathway, and is mediated through p21(CIP1/WAF1) activation in SNU-16 cells.
Insights
Activin A inhibits human gastric cancer SNU-16 cell proliferation by regulating activin receptors and Smad signaling. This process involves the activation of p21(CIP1/WAF1), a key cell cycle inhibitor, suggesting a novel therapeutic target.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Gastric cancer is a significant global health concern with complex molecular underpinnings.
- Activin signaling pathways play crucial roles in cell proliferation and differentiation, but their role in gastric cancer remains incompletely understood.
- Understanding the molecular mechanisms regulating gastric cancer cell growth is essential for developing targeted therapies.
Purpose of the Study:
- To investigate the regulatory role of activin in human gastric cancer cell line SNU-16 proliferation.
- To examine the impact of activin on mRNA expression levels of activin receptors, Smads, and p21(CIP1/WAF1) in SNU-16 cells.
- To elucidate the signaling pathway through which activin influences gastric cancer cell growth.
Main Methods:
- Cultured human gastric cancer cell lines, including SNU-16, and purified RNA.
- Utilized Reverse Transcription Polymerase Chain Reaction (RT-PCR) to analyze mRNA expression of key genes (activin receptors, Smads, p21(CIP1/WAF1)).
- Treated SNU-16 cells with activin A and measured cell proliferation using MTT assay over 24, 48, and 72 hours.
Main Results:
- Activin A significantly down-regulated the proliferation of SNU-16 cells, while other gastric cancer cell lines showed no significant changes.
- Differential expression patterns of inhibin/activin subunits, activin receptors, Smads, and p21(CIP1/WAF1) were observed across various gastric cancer cell lines.
- Activin A treatment in SNU-16 cells led to decreased ActR IA, IB, IIA mRNA, increased ActR IIB mRNA, altered Smad4 and Smad7 expression, and a peak in p21(CIP1/WAF1) mRNA at 72 hours.
Conclusions:
- Activin-induced inhibition of cell growth in SNU-16 cells is mediated by the activation of p21(CIP1/WAF1).
- The negative feedback effect of Smad7 on the activin signaling pathway plays a crucial role in this growth inhibition.
- These findings suggest that the activin signaling pathway, particularly involving Smad7 and p21(CIP1/WAF1), is a potential therapeutic target for gastric cancer treatment.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Negative Regulator Molecules
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

